This breakthrough comes via Second Sight, a California company whose ... As of now, only people with severe cases of retinitis pigmentosa qualify to receive a bionic eye. Among them is Lisa ...

A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...

That patient, a 58-year-old man, was diagnosed with retinitis pigmentosa at age 18. Bionic Sight has firsthand experience ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The ...

It occurs in individuals who have lost a significant portion of their sight due to age-related macular degeneration, retinitis pigmentosa ... than normal—for example, they may see people ...

Background: Retinitis Pigmentosa (RP) is a hereditary genetic ... reduction in the Quality of life of the patients. Second Sight Medical Products Inc. developed Argus II, a retinal prosthesis ...

Mouse embryonic stem cells have been successfully used by scientists to replace diseased retinal cells and restore sight in a mouse model of retinitis pigmentosa. Mouse embryonic stem cells have ...

The FDA granted rare pediatric disease designation to VG901 for the treatment of retinitis pigmentosa caused by mutations in ...

Two compounds prolonged the survival of photoreceptors in a retinitis pigmentosa mouse model for rod opsin misfolding ...

Alex Innes was diagnosed with retinitis pigmentosa at about 10 years old A man who lost most of his sight eight years ago said companies needed to do more to employ and support people with ...

A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...